| Stage | ARES | % of rev | BX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.4B | 100.00% | $5.0B | 100.00% | BX ×3.53 |
| Gross profit | $740M | 51.80% | $5.0B | 100.00% | BX +48.2pp |
| Operating income | $249M | 17.40% | $2.7B | 52.90% | BX +35.5pp |
| Pre-tax income | $386M | 27.02% | $2.8B | 55.68% | BX +28.7pp |
| Net income | $151M | 10.54% | $2.4B | 46.71% | BX +36.2pp |
| Stage | ARES | BX | Gap · A − B |
|---|---|---|---|
| Revenue | $1.4B100.00% | $5.0B100.00% | BX ×3.53 |
| Gross profit | 51.80%$740M | 100.00%$5.0B | BX +48.2pp |
| Operating income | 17.40%$249M | 52.90%$2.7B | BX +35.5pp |
| Pre-tax income | 27.02%$386M | 55.68%$2.8B | BX +28.7pp |
| Net income |
| 10.54%$151M |
| 46.71%$2.4B |
| BX +36.2pp |